Clinical TrialsSearch results
Number of results: 233
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized Controlled Trial to Evaluate Radiotherapy Followed by Endocrine Therapy vs. Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy(JCOG0401)
- prostate cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22
Other
- Outcome study of hormonal therapy for prostate cancer in Japan
- Prostate cancer
- J-CaP study group
- 2005-09-29
Other
- Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.
- Prostate cancer
- J-CaP study group
- 2006-12-30
Recruiting
- Glove stocking study for Decetaxel -induced peripheral neuropathy
- prostate cancer
- Kato Takuma
- 2021-03-11
Completed
- Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide
- Prostate Cancer
- Sugimoto Mikio
- 2019-02-27
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Phase III Randomized Study of Imatinib therapy in chornic phase chronic myeloid leukemia comparing standard dose-escalation with progressive dose-escalation (JALSG CML207study)
- Previously untreated Chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2007-09-15
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- Phase II study of ABVd therapy for the previously untreated patients with stage II to IV Hodgkin' s disease (JCOG 9305, LSG14)
- previouly untreated advanced stage Hodgkin lymphoma (stage II, III, IVy)
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30